In the BioHarmony Drug Report Database

"Preview" Icon

Panitumumab

Vectibix (panitumumab) is an antibody pharmaceutical. Panitumumab was first approved as Vectibix on 2006-09-27. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. The pharmaceutical is active against epidermal growth factor receptor.

 

Trade Name

 

Vectibix
 

Common Name

 

panitumumab
 

ChEMBL ID

 

CHEMBL1201827
 

Indication

 

colorectal neoplasms
 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Panitumumab structure rendering